Company Analysis

Citius Pharmaceuticals, Inc. (CTXR)

Nasdaq: CTXR · Pharmaceutical Preparations · Cranford, NJ · filing with the SEC since 2010
Grade3.6
◀ Past 5.2● Present 3.1▶ Future 3.0
3 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in September.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingSep 30, 2025Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021Sep 30, 2020Sep 30, 2019Sep 30, 2018Sep 30, 2017Sep 30, 2016
Report filedDec 23, 2025Dec 27, 2024Dec 29, 2023Dec 22, 2022Dec 15, 2021Dec 16, 2020Dec 16, 2019Dec 11, 2018Dec 13, 2017·
Revenue···90,00090,00090,00090,00075,00050,000·
For lenders
Net interest income·········806
Cost of revenue·······75,00050,00045,000
Research and development9,156,47411,906,60114,819,72917,655,48212,240,5038,812,8108,596,8986,562,9252,936,2522,933,199
General and administrative18,532,84318,249,40215,295,58411,754,6099,836,4128,094,6146,285,4806,446,5176,063,4393,783,941
Total operating expenses38,525,60841,995,68136,732,01833,316,04523,531,89417,710,68515,598,36113,789,1439,986,3117,449,291
Operating income-38,525,608-41,995,681-36,732,018-33,316,045-23,531,894-17,710,685-15,598,361-13,789,143-9,986,311-7,449,291
Interest expense49,750···1,23315,67316,44315,838850,7898,994
Interest and investment income110,081758,0001,179,417251,399261,82568,06652,660··806
Share of profit of equity-method investments·····110,207····
Other income (expense), net·········460,000
Total non-operating income (expense)-157,7013,145,8424,765,106251,399477,460162,60036,2171,252,505-398,642-846,407
Income before income taxes-38,683,309-38,849,839-31,966,912-33,064,646-23,054,434-17,548,085-15,562,144r12,536,638r10,384,953r-8,295,698
Income tax expense1,056,960576,000576,000576,0001,233741····
Net income including non-controlling interests-39,740,269-39,425,839-32,542,912-33,640,646-23,054,434-17,548,085-15,562,144-12,536,638-10,384,953·
Net income to non-controlling interests-2,306,358-287,000········
Net income··-32,542,912-33,640,646-23,054,434-17,548,085-15,562,144-12,536,638-10,384,953-8,295,698
Preferred dividends····1,450,876·····
Net income to common shareholders-37,433,911-40,186,151-33,694,120-33,640,646-24,505,310-17,548,085····
Earnings per share, basic-3.38-5.97-5.57-5.75b-5.75b·····
Earnings per share, diluted-3.38-5.97-5.57-5.75b-5.75b·····
Earnings per share, basic and diluted····-5.75b-11.25b-19.25b-29.25b-47.25b-57.25rb
Weighted average shares, basic11,065,2256,726,9996,051,789r5,843,296b4,343,963b·····
Weighted average shares, diluted11,065,2256,726,9996,051,789r5,843,296b4,343,963b·····
Weighted average shares, basic and diluted····4,343,963b1,566,610b806,474b429,275b219,300b144,928rb
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton CTXR · research, not advice